Dermatology · Pensacola, FL
NPI
1699115014
Since 2013
Specialty
Dermatology
Code 207N00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
530 Fontaine St
Pensacola, FL, 32503
Phone (850) 474-4775
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.9M
6,957 services
Medicare patients, 2024
1,486
Average age 78
Drug cost, 2024
$111K
4,089 prescriptions
Company payments, 2025
$39.91
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Luke A Hyder was code 17311 (mohs surgery), 1,547 times for 1,121 patients. In total Luke A Hyder billed 6,957 services in 109 codes, and Medicare paid $1.9M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-05-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17311 Mohs Surgery | Office | 1,547 | 1,121 | $452.55 | $700K |
| 13132 Wound Repair - All Levels | Office | 611 | 524 | $187.14 | $114K |
| 88331 Surgical Pathology Examination | Office | 529 | 326 | $79.01 | $42K |
| 17312 Mohs Surgery | Office | 493 | 372 | $323.39 | $159K |
| Q4159 Affinity, per square centimeter | Office | 370 | 16 | $271.16 | $100K |
| 17313 Mohs Surgery | Office | 370 | 314 | $470.69 | $174K |
| 11102 Skin Biopsy | Office | 361 | 294 | $47.29 | $17K |
| 13121 Wound Repair - All Levels | Office | 289 | 264 | $178.91 | $52K |
| 15260 Skin Grafting | Office | 216 | 208 | $785.75 | $170K |
| 17250 Destruction Skin Lesion | Office | 168 | 135 | $60.21 | $10K |
| 12032 Wound Repair - All Levels | Office | 150 | 139 | $142.16 | $21K |
| 17262 Destruction Skin Lesion | Office | 148 | 114 | $88.38 | $13K |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 140 | 32 | $0.75 | $106 |
| 17003 Destruction Skin Lesion | Office | 102 | 21 | $5.13 | $524 |
| 11103 Skin Biopsy | Office | 94 | 60 | $39.61 | $3,724 |
By year: 2022 $1.1M for 4,849 services; 2023 $1.5M for 6,112 services; 2024 $1.9M for 6,957 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 88331 Surgical Pathology Examination | 529 | 326 | $79.01 | $42K |
| 88342 Immunohistochemistry | 66 | 57 | $82.29 | $5,431 |
Medicare prescription drug claims, 2024
In 2024, the drug Luke A Hyder prescribed most often to Medicare patients was Doxycycline Monohydrate, with 1,986 prescriptions and refills. In total Luke A Hyder wrote 4,089 Medicare prescriptions that cost $111K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Doxycycline Monohydrate Generic | 1,986 | 1,986 | 1,549 | $17K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 1,284 | 1,284 | 1,030 | $4,955 |
| Tramadol Hcl Generic | 303 | 303 | 272 | $371 |
| Mupirocin Generic | 76 | 76 | 69 | $659 |
| Cephalexin Generic | 59 | 59 | 54 | $447 |
| Ciprofloxacin Hcl Generic | 53 | 53 | 45 | $399 |
| Clobetasol Propionate Generic | 40 | 40 | 35 | $1,300 |
| Doxycycline Hyclate Generic | 36 | 36 | 30 | $315 |
| Fluorouracil Generic | 34 | 35 | 32 | $2,220 |
| Fluconazole Generic | 32 | 57 | 25 | $494 |
| Lorazepam Generic | 22 | 22 | 21 | $34.23 |
| Triamcinolone Acetonide Generic | 19 | 19 | 15 | $235 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 16 | 16 | Under 11 | $50.53 |
| Metronidazole Generic | 15 | 15 | Under 11 | $478 |
| Valacyclovir Valacyclovir Hcl | 11 | 11 | Under 11 | $286 |
Brand drugs: - claims; generic drugs: 4,079 claims; opioid claims: 1,607.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Luke A Hyder $39.91 ($39.91 in general payments such as food, travel and fees) from 1 company. The largest payer was Organogenesis Inc. with $39.91.
| Company | Payments | Amount |
|---|---|---|
| Organogenesis Inc. ORGO | 2 | $39.91 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.